Your browser doesn't support javascript.
loading
Updated assessment of risks and benefits of dolutegravir versus efavirenz in new antiretroviral treatment initiators in sub-Saharan Africa: modelling to inform treatment guidelines.
Phillips, Andrew N; Bansi-Matharu, Loveleen; Venter, Francois; Havlir, Diane; Pozniak, Anton; Kuritzkes, Daniel R; Wensing, Annemarie; Lundgren, Jens D; Pillay, Deenan; Mellors, John; Cambiano, Valentina; Jahn, Andreas; Apollo, Tsitsi; Mugurungi, Owen; Ripin, David; Da Silva, Juliana; Raizes, Elliot; Ford, Nathan; Siberry, George K; Gupta, Ravindra K; Barnabas, Ruanne; Revill, Paul; Cohn, Jennifer; Calmy, Alexandra; Bertagnolio, Silvia.
Affiliation
  • Phillips AN; Institute for Global Health, University College London, London, UK. Electronic address: andrew.phillips@ucl.ac.uk.
  • Bansi-Matharu L; Institute for Global Health, University College London, London, UK.
  • Venter F; Ezintsha, Wits Reproductive Health and HIV Institute, University of the Witwatersrand, Johannesburg, South Africa.
  • Havlir D; School of Medicine, University of California San Francisco, San Francisco, CA, USA.
  • Pozniak A; Chelsea and Westminster Hospital, London, UK; London School of Hygiene & Tropical Medicine, London, UK.
  • Kuritzkes DR; Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Wensing A; Ezintsha, Wits Reproductive Health and HIV Institute, University of the Witwatersrand, Johannesburg, South Africa; University Medical Center Utrecht, Utrecht, Netherlands.
  • Lundgren JD; Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
  • Pillay D; Africa Health Research Institute, Mtubatuba, South Africa.
  • Mellors J; Department of Medicine, Division of Infectious Diseases, University of Pittsburgh, Pittsburgh, PN, USA.
  • Cambiano V; Institute for Global Health, University College London, London, UK.
  • Jahn A; Ministry of Health, Lilongwe, Malawi.
  • Apollo T; Ministry of Health and Child Care, Harare, Zimbabwe.
  • Mugurungi O; Ministry of Health and Child Care, Harare, Zimbabwe.
  • Ripin D; Clinton Health Access Initiative, New York, NY, USA.
  • Da Silva J; Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Raizes E; Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Ford N; Centre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town, South Africa; WHO, Geneva, Switzerland.
  • Siberry GK; Office of HIV/AIDS, Global Health Bureau, United States Agency for International Development, Arlington, VA, USA.
  • Gupta RK; Cambridge Institute of Immunology and Infectious Diseases, University of Cambridge, Cambridge, UK.
  • Barnabas R; Department of Global Health, University of Washington, Seattle, WA, USA.
  • Revill P; Centre for Health Economics, University of York, York, UK.
  • Cohn J; Elizabeth Glaser Paediatric Health Foundation, Washington, DC, USA.
  • Calmy A; HIV/AIDS Unit, Geneva University Hospital, University of Geneva, Geneva, Switzerland.
  • Bertagnolio S; WHO, Geneva, Switzerland.
Lancet HIV ; 7(3): e193-e200, 2020 03.
Article in En | MEDLINE | ID: mdl-32035041
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / Anti-HIV Agents / Benzoxazines / Heterocyclic Compounds, 3-Ring Type of study: Clinical_trials / Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Aspects: Patient_preference Limits: Adolescent / Adult / Female / Humans / Male / Middle aged / Pregnancy Country/Region as subject: Africa Language: En Journal: Lancet HIV Year: 2020 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / Anti-HIV Agents / Benzoxazines / Heterocyclic Compounds, 3-Ring Type of study: Clinical_trials / Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Aspects: Patient_preference Limits: Adolescent / Adult / Female / Humans / Male / Middle aged / Pregnancy Country/Region as subject: Africa Language: En Journal: Lancet HIV Year: 2020 Document type: Article Country of publication: